Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04165915
Other study ID # RECHMPL19_0513
Secondary ID
Status Completed
Phase
First received
Last updated
Start date September 1, 2017
Est. completion date April 30, 2019

Study information

Verified date November 2019
Source University Hospital, Montpellier
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

•Background: PAERPA experimentation implemented in the East-Herault region since September 2017 aims to identify fragility and prevent the risk of loss of autonomy in elderly persons older than 60 years by facilitating coordination between Professionals taking care of the patient with the personalized health plan " PPS". The main objective of this study was to evaluate the implementation of this device through the achievement or not of the objectives set by the PPS.

•Methods: Descriptive cohort study with retrospective inclusion and prospective follow-up from the East Herault CTA database. All patients over 60 years old living at home and having a PPS written between September 2017 and April 2018 were included. PPS monitoring for 1 year. Description of this population then analysis of PPS.

•Discussion: Our study aims to evaluate the implementation of the device to identify ways to improve the device for the management of subjects at risk of loss of autonomy.


Recruitment information / eligibility

Status Completed
Enrollment 137
Est. completion date April 30, 2019
Est. primary completion date April 1, 2019
Accepts healthy volunteers No
Gender All
Age group 60 Years and older
Eligibility Inclusion Criteria:

An individual must fulfill all of the following criteria in order to be eligible for study enrollment:

- Aged of 60 years and more

- individual health care plan was prepared

- living in the Est-Héraultais territory

Exclusion Criteria:

- Hospitalized patients

- Patients who declined to have an individual heath care planPsychosis

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
France Uhmontpellier Montpellier

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Montpellier

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Estimating goals set by the PPS (personalized health plan) achievement of objectives established in the individual health care plan after 6 and 12 month follow-up 6 and 12 month follow-up
Secondary correlation between unwillingness and cognitive disorder correlation between unwillingness and cognitive disorder 1 day
Secondary Correlation between unwillingness and numbers of established goals Correlation between unwillingness and numbers of established goals 1 day
Secondary Correlation between unwillingness and locomotors goals Correlation between unwillingness and locomotors goals 1 day